Understanding Appetite Regulation and Satiety with GLP-1 Agonists
Appetite regulation and satiety are key mechanisms in GLP-1 receptor agonist clinical evidence. These medications help reduce weight by suppressing appetite and improving metabolic effects. Understanding these processes supports better clinical decisions…
Differentiating Lipedema from Obesity in GLP-1 Receptor Agonist Therapy
GLP-1 receptor agonist lipedema differentiation is crucial for effective obesity treatment. Understanding the differences between lipedema and obesity ensures better patient outcomes. This approach guides appropriate use of semaglutide and tirzepatide…
Can Medicinal Plants Help Fight Antibiotic-Resistant Infections? A Review of the Evidence
This 2024 review examines medicinal plants antibacterial wound healing properties and their potential against antibiotic-resistant infections. While promising in vitro, clinical evidence remains limited. Natural biopolymer wound dressings show more…
Herbal Supplements and Surgery: What Your Anesthesiologist Needs to Know
Herbal supplements perioperative interactions pose important risks during surgery. Many patients do not disclose their herbal use, increasing potential anesthesia complications. Understanding these interactions helps improve surgical safety and outcomes.
Cannabinoids for Acute Pain: Strong Biology, Weak Clinical Evidence
Cannabinoid analgesia acute pain research reveals a strong biological basis but inconsistent clinical evidence. The endocannabinoid system offers promising pain modulation pathways. However, current trials lack sufficient power to confirm cannabinoids'…
CBD for Oral Diseases: Promising Preclinical Science, But Clinical Evidence Is Still Missing
This 2024 review explores cannabidiol pharmacology oral medicine and its therapeutic potential in oral diseases. The evidence is mainly preclinical, with no clinical trials yet. CBD shows promise in periodontal and oral cancer research but lacks clinical…
CBD and Colon Cancer: A Promising Hypothesis Built on Preclinical Ground
By influencing the serotonergic system, CBD colorectal cancer serotonergic pathway may confer both protective and potentially deleterious effects during CRC development. This 2025 review synthesizes preclinical evidence without human clinical trials. The…
Your Body Fights Back, But Your Doctor Has Options
Clinical Takeaway GLP-1 plateaus happen because the body adapts by slowing metabolism and increasing hunger signals over time. Clinicians may adjust dosing, add adjunct therapies, or address behavioral factors to push past the stall. Your Body Fights…
Same Drug, Different Goals: GLP-1s Treat More Than Sugar
Clinical Takeaway GLP-1 medications like semaglutide are FDA-approved for both type 2 diabetes management and chronic weight loss, but the target doses, titration schedules, and treatment goals can differ significantly between the two indications. Talk…
GLP-1 Receptor Agonist Clinical Evidence: Mental Health Links
Emerging research highlights GLP-1 receptor agonist mental health benefits beyond metabolic effects. Semaglutide shows promise in improving mood and psychiatric outcomes. Clinicians should consider these findings in patient care.